rs333
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
The NM_001394783.1(CCR5):βc.554_585delβ(p.Ser185IlefsTer32) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0977 in 1,613,870 control chromosomes in the GnomAD database, including 8,868 homozygotes. Variant has been reported in ClinVar as Benign (β ).
Frequency
Genomes: π 0.072 ( 553 hom., cov: 31)
Exomes π: 0.10 ( 8315 hom. )
Consequence
CCR5
NM_001394783.1 frameshift
NM_001394783.1 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.894
Genes affected
CCR5 (HGNC:1606): (C-C motif chemokine receptor 5) This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. An allelic polymorphism in this gene results in both functional and non-functional alleles; the reference genome represents the functional allele. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCR5 | NM_001394783.1 | c.554_585del | p.Ser185IlefsTer32 | frameshift_variant | 2/2 | ENST00000292303.5 | NP_001381712.1 | |
CCR5AS | NR_125406.1 | n.392-2067_392-2036del | intron_variant, non_coding_transcript_variant | |||||
CCR5 | NM_000579.4 | c.554_585del | p.Ser185IlefsTer32 | frameshift_variant | 3/3 | NP_000570.1 | ||
CCR5 | NM_001100168.2 | c.554_585del | p.Ser185IlefsTer32 | frameshift_variant | 3/3 | NP_001093638.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCR5 | ENST00000292303.5 | c.554_585del | p.Ser185IlefsTer32 | frameshift_variant | 2/2 | 1 | NM_001394783.1 | ENSP00000292303 | P1 | |
CCR5AS | ENST00000701879.1 | n.174-2067_174-2036del | intron_variant, non_coding_transcript_variant | |||||||
CCR5 | ENST00000445772.1 | c.554_585del | p.Ser185IlefsTer32 | frameshift_variant | 1/1 | ENSP00000404881 | P1 | |||
CCR5AS | ENST00000451485.2 | n.392-2067_392-2036del | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0718 AC: 10911AN: 152034Hom.: 553 Cov.: 31
GnomAD3 genomes
AF:
AC:
10911
AN:
152034
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0743 AC: 18640AN: 251006Hom.: 966 AF XY: 0.0745 AC XY: 10108AN XY: 135678
GnomAD3 exomes
AF:
AC:
18640
AN:
251006
Hom.:
AF XY:
AC XY:
10108
AN XY:
135678
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.100 AC: 146811AN: 1461718Hom.: 8315 AF XY: 0.0983 AC XY: 71450AN XY: 727168
GnomAD4 exome
AF:
AC:
146811
AN:
1461718
Hom.:
AF XY:
AC XY:
71450
AN XY:
727168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0717 AC: 10914AN: 152152Hom.: 553 Cov.: 31 AF XY: 0.0707 AC XY: 5259AN XY: 74390
GnomAD4 genome
AF:
AC:
10914
AN:
152152
Hom.:
Cov.:
31
AF XY:
AC XY:
5259
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
43
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4Other:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
CCR5-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Susceptibility to HIV infection Benign:1
protective, no assertion criteria provided | literature only | OMIM | Dec 01, 2008 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 22, 2019 | - - |
Resistance to hepatitis C virus Benign:1
protective, no assertion criteria provided | literature only | OMIM | Dec 01, 2008 | - - |
West Nile virus, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Dec 01, 2008 | - - |
Multiple sclerosis modifier of disease progression Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Dec 01, 2008 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at